Evidence map›Paper›PMID 33799580›Full record

ReviewMolecules (Basel, Switzerland)2021

Postbiotics, Metabolic Signaling, and Cancer.

Nikola Vrzáčková, Tomáš Ruml, Jaroslav Zelenka

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. A novel postbiotic fromJournal of traditional and complementary medicine · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Appraisal of postbiotics in cancer therapy.Frontiers in pharmacology · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nikola VrzáčkováDepartment of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.
Tomáš RumlDepartment of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0002-5698-4366
Jaroslav ZelenkaDepartment of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 16628 Prague, Czech Republic.ORCID 0000-0001-8145-8037
University of Chemistry and Technology, Prague · CZ

Funding

Grantová Agentura České Republiky 21-11688S
6 · The paper itself

Abstract

Postbiotics are health-promoting microbial metabolites delivered as a functional food or a food supplement. They either directly influence signaling pathways of the body or indirectly manipulate metabolism and the composition of intestinal microflora. Cancer is the second leading cause of death worldwide and even though the prognosis of patients is improving, it is still poor in the substantial part of the cases. The preventable nature of cancer and the importance of a complex multi-level approach in anticancer therapy motivate the search for novel avenues of establishing the anticancer environment in the human body. This review summarizes the principal findings demonstrating the usefulness of both natural and synthetic sources of postbotics in the prevention and therapy of cancer. Specifically, the effects of crude cell-free supernatants, the short-chain fatty acid butyrate, lactic acid, hydrogen sulfide, and β-glucans are described. Contradictory roles of postbiotics in healthy and tumor tissues are highlighted. In conclusion, the application of postbiotics is an efficient complementary strategy to combat cancer.

Indexed as

beta-GlucansButyratesDietary SupplementsFatty Acids, VolatileGastrointestinal MicrobiomeHumansHydrogen SulfideLactic AcidMetabolomeNeoplasmsPrebioticsProbioticsbeta-GlucansButyratesFatty Acids, VolatileHydrogen SulfideLactic AcidPrebioticscolorectal cancerfunctional foodGPR81intestinal metabolomemicrobiomeSCFA

Identifiers

PMID33799580
PMCPMC8000401
OpenAlexW3134131614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.